激酶
细胞周期蛋白依赖激酶
淫羊藿苷
信号转导
蛋白激酶B
STAT蛋白
化学
激活剂(遗传学)
体内
MAPK/ERK通路
药理学
细胞周期
车站3
细胞生物学
生物
细胞
生物化学
受体
医学
替代医学
生物技术
病理
作者
Can-Jing Zhang,Xiangyu Sui,Yudong Jiang,Xuanyi Wang,Songmei Wang
出处
期刊:Discovery Medicine
日期:2020-01-01
卷期号:29 (156): 5-16
被引量:19
摘要
Traditional Chinese Medicine (TCM) has been increasingly studied for antitumor activities. Icaritin, a hydrolytic product of icariin, is an effective ingredient of the traditional Chinese herb epimedium with multiple pharmacological activities. Among them, the antitumor activity of icaritin has been widely studied and reported in tumors both in vitro and in vivo. While its exact antitumor mechanisms await revelation, icaritin has been found to regulate several key molecules and pathways concerning cell fate, including CDK-dependent pathways, mitogen-activated protein kinases (MAPKs), the serine-threonine kinase AKT, signal transducer and activator of transcription 3 (STAT3), and p53. The ability to induce cellular oxidative stress also contributes to its antitumor activity. This review outlines the results of key investigations focusing on the antitumor effects and mechanisms of icaritin.
科研通智能强力驱动
Strongly Powered by AbleSci AI